Henry Schein is a Fortune 500 company and one of the global leaders in its industry, providing healthcare solutions, as well ...

On Tuesday, Henry Schein Inc. (NASDAQ:HSIC) reported a third-quarter adjusted EPS of $1.22, down 7.6% year-over-year, beating ...

Analyst Erin Wright of Morgan Stanley maintained a Sell rating on Henry Schein (HSIC – Research Report), retaining the price target of ...

The dental supplies firm raised the lower end of its 2024 adjusted earnings projection, and now anticipates a range between $4.74 and $4.82 a share, compared with the prior $4.70-to-$4.82 a share ...

MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq ... Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more ...

Henry Schein (HSIC – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael ...

Dental care supplier Henry Schein advanced in Monday trading as investors bet that Robert F. Kennedy Jr., President-elect ...

Good morning, ladies and gentlemen, and welcome to Henry Schein's Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a ...

Analysts' ratings for Henry Schein (NASDAQ ... engaged in combining global dental and medical businesses and distributes consumable products, small equipment, laboratory products, and Vitamins.

Sales growth reflects 3.2% growth from acquisitions, a 0.2% decrease resulting from foreign currency exchange rates, a 0.4% decrease from lower sales of personal protective equipment (PPE ...